Reflectance confocal microscopy identification of subclinical basal cell carcinomas during and after vismodegib treatment
Journal of the European Academy of Dermatology and Venereology Nov 08, 2017
Couzan C, et al. - Among patients with multiple basal cell carcinomas (BCCs) treated by vismodegib, the authors assessed specificity and sensitivity of clinical, dermoscopic and reflectance confocal microscopy (RCM) examination for BCC. RCM was a non-invasive technique. During and after vismodegib treatment, it could detect subclinical residual BCC, thus helping the clinician to identify incomplete tumor regression.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries